Tanshinone IIA attenuates Aβ 25-35 -induced spatial memory impairment via upregulating receptors for activated C kinase1 and inhibiting autophagy in hippocampus

• Published in: Journal of pharmacy and pharmacology Vol. 69; no. 2; p. 191
• Main Authors: Zhu, Jiejun, Liao, Shiping, Zhou, Liming, Wan, Lihong
• Format: Journal Article
• Language: English
• Published: England 01.02.2017
• Subjects: Abietanes - pharmacology; Abietanes - therapeutic use; Amyloid beta-Peptides - toxicity; Animals; Autophagy - drug effects; Beclin-1 - metabolism; Extracellular Signal-Regulated MAP Kinases - metabolism; Hippocampus - metabolism; Male; Maze Learning - drug effects; Memory Disorders - chemically induced; Memory Disorders - prevention & control; Mice; Microtubule-Associated Proteins - metabolism; Neuropeptides - metabolism; Neuroprotective Agents - pharmacology; Peptide Fragments - toxicity; Receptors for Activated C Kinase; RNA, Small Interfering - pharmacology; Up-Regulation - drug effects; receptors for activated C kinase1; Tanshinone IIA; autophagy; spatial memory impairment; Aβ25-35
• ISSN: 2042-7158

Tanshinone IIA (Tan IIA) may exert significant protective effects against the neurotoxicity induced by β-amyloid protein (Aβ). This study was designed to investigate the possible neuroprotective mechanism of Tan IIA on Aβ -induced spatial memory impairment in mice. After 3 weeks of preventive treatment (Tan IIA or oil), all male Kunming mice were subjected to Aβ (10 μl, intracerebroventricularly (i.c.v.)) to establish the spatial memory impairment model. The Morris water maze (MWM), haematoxylin and eosin staining, real-time PCR and Western blot were performed to determine the ability of spatial memory, neuronal damage and expression of extracellular signal-regulated kinase (ERK), receptors for activated C kinase1 (RACK1) and autophagy-related genes. Additionally, ShRACK1 was used to decrease the level of RACK1 in the hippocampus to test Beclin1 in hippocampus by real-time PCR and Western blot. Tanshinone IIA (Tan IIA, 80 mg/kg) administration notably protected mice from Aβ -induced spatial memory impairment and neurotoxicity, increased pERK/ERK and the expression of RACK1, and reduced the elevated levels of BECLIN1 and LC3-II/I in the hippocampus. In addition, ShRACK1 i.c.v markedly upregulated BECLIN1 level, but not altered Beclin1 mRNA expression in the hippocampus. Tanshinone IIA may exert neuroprotective effects via upregulating RACK1 and inhibiting autophagy in the hippocampus of mice.